ECLERALIMAB
UNII A90I978U7Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Ecleralimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A90I978U7Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2415207-91-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
A90I978U7Q
CAS Registry Number
2415207-91-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ECLERALIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C184862
National Cancer Institute reference terminology for clinical and research data.
INN ID
11791
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ecleralimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ECLERALIMAB

Common Names & Synonyms

ECLERALIMAB [INN]
IMMUNOGLOBULIN IGG1 FAB FRAGMENT, ANTI-(HUMAN THYMIC STROMAL LYMPHOPOIETIN) (HUMAN MONOCLONAL NVS280929 .GAMMA.-1 CHAIN), DISULFIDE WITH HUMAN MONOCLONAL NVS280929 .LAMBDA.-CHAIN

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus